The announcement of workforce reduction and strategic changes by Emergent BioSolutions is likely to have a short-term negative impact on the stock price due to potential concerns over the company's current financial health and the costs associated with these changes. However, the long-term effect could be positive if these measures lead to improved financial stability and operational efficiency.